SD
Sagar Dhumal
About Sagar Dhumal
Data last updated:
Sagar Dhumal is an Additional Director at Stepcure Pharma Private Limited (since 2023) and Director at Joras Oncology Private Limited (since 2011). The companies operate in Trading and Chemicals. The 2 current companies with reported revenue have a combined latest revenue of ₹2.24 Cr; the largest is Stepcure Pharma Private Limited at ₹1.38 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Stepcure Pharma Private Limited U74999PN2018PTC174943 | Additional Director | 03 Feb 2023 | 2018 | ₹1.38 Cr (FY 2025) | Active |
 Joras Oncology Private Limited U24233PN2011PTC155916 | Director | 02 Sep 2011 | 2011 | ₹86 Lakh (FY 2017) | Active |
Board colleagues of Sagar Dhumal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Janardhan Vithoba Dhumal | 07267191 | Stepcure Pharma Private Limited | Director |
| Ashish Anantram Khorgade | 03605527 | Joras Oncology Private Limited | Director |
| Ashwin Shroff Prakash | 06430352 | Joras Oncology Private Limited | Director |
| Nilesh Pandurang Belhe | 03597033 | Joras Oncology Private Limited | Director |
| Sunil Shivaji Kamble | 07760269 | Joras Oncology Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sagar Dhumal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sagar Dhumal
Sagar Dhumal currently holds 2 directorships: Stepcure Pharma Private Limited (Additional Director, since 03 Feb 2023, revenue ₹1.38 Cr (FY 2025)); Joras Oncology Private Limited (Director, since 02 Sep 2011, revenue ₹86 Lakh (FY 2017)).
Sagar Dhumal was first appointed on 02 Sep 2011 as Director at Joras Oncology Private Limited. The most recent appointment on record is 03 Feb 2023 at Stepcure Pharma Private Limited.
The 2 current companies of Sagar Dhumal that report revenue have a combined latest revenue of ₹2.24 Cr: Stepcure Pharma Private Limited ₹1.38 Cr (FY 2025); Joras Oncology Private Limited ₹86 Lakh (FY 2017).
The current boards of Sagar Dhumal's companies include Janardhan Vithoba Dhumal (Stepcure Pharma Private Limited), Ashish Anantram Khorgade (Joras Oncology Private Limited), Ashwin Shroff Prakash (Joras Oncology Private Limited), Nilesh Pandurang Belhe (Joras Oncology Private Limited), Sunil Shivaji Kamble (Joras Oncology Private Limited).